Eir Ventures invests in Henlez

Eir Ventures invests in Henlez

Henlez mission is to transform the management of skin conditions by using enzymes. Henlez’s pre-clinical lead development program, HEN-001, is an enzyme-based, topical application directed towards hidradenitis suppurativa (HS) – a highly stigmatizing and chronic...
Eir Ventures invests in Hoba Therapeutics

Eir Ventures invests in Hoba Therapeutics

Hoba Therapeutics is Danish biotech developing restorative treatments for pain, hearing loss, and sensory neuron disorders. HB-086 is under development  for the treatment of pain in multiple chronic neuropathic pain indications. HB-086 is a non-opioid compound with a...